Trial Profile
An open label, randomised, pilot trial of pegylated interferon, ribavirin and telaprevir versus pegylated interferon and ribavirin alone in the response guided treatment of acute hepatitis C genotype 1 virus infection in patients with HIV-1 co-infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jul 2017
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Registrational; Therapeutic Use
- 31 Jul 2017 Status changed from recruiting to completed.
- 25 Sep 2013 New trial record